New call-to-action
New call-to-action
New call-to-action

Advancing Prader-Willi Syndrome Care With the PWS Profile

The PWS-Profile provides an assessment tool for evaluating therapies for PWS.

Prader-Willi syndrome (PWS) impacts many parts of our children’s lives. While the hallmark challenge is hyperphagia—an uncontrollable, excessive appetite—there’s much more beneath the surface. Children and adults with PWS often face behavioral and emotional struggles, including anxiety, rigid thinking, repetitive questioning, temper outbursts, and skin picking. These symptoms can affect not only the individual but also their entire family’s quality of life.

Advancing Prader-Willi Syndrome Care With the New PWS Profile ToolAs a patient advocacy organization, FPWR is deeply committed to accelerating research that leads to effective treatments for all these challenges. To do that, researchers need reliable ways to measure whether new medicines or therapies truly make a difference.

 

 

 

 

Why Measuring PWS Symptoms Is So Important—and So Challenging

When developing new treatments, researchers need a reliable way to show potential improvements in symptoms.

For many medical conditions, measuring treatment success is straightforward. For example, changes in weight or blood hormone levels are easy to track. But with PWS, many of the symptoms are behavioral or emotional features that are complex and unique to this syndrome. This makes it difficult for researchers to prove whether a new treatment is working.

To solve this problem, researchers need tools specifically designed for PWS—tools that can capture the real-life struggles our loved ones face every day, like rigid thinking, anxiety and depressive symptoms, repetitive questions, temper outbursts, and skin picking.

 

Introducing the PWS Profile: A Breakthrough Assessment Tool

Until recently, the only well-established measure for PWS clinical trials was the Hyperphagia Questionnaire for Clinical Trials (HQ-CT), which helps evaluate hyperphagic behaviors that are common in PWS. But what about all the other behavioral and emotional symptoms?

Thanks to a dedicated research team at Vanderbilt University, including Elisabeth Dykens, Elizabeth Roof, and Haille Hunt-Hawkins, a tool called the PWS Profile was developed. They recognized the critical need for a PWS-specific tool to evaluate treatment efficacy in clinical trials aimed at reducing behavioral and emotional problems in PWS, and designed a tool to specifically measure the full range of PWS-specific behaviors and emotional challenges, extending beyond hyperphagia.

 

How Was the PWS Profile Developed?

Creating the PWS Profile took years of collaboration between researchers, families, and clinical experts. The team worked closely with parents of individuals with PWS to ensure the questionnaire truly reflects real-world experiences.

The final questionnaire includes 57 carefully crafted questions, and was tested with 761 parents of children and adults with PWS aged 5 and up through the Global PWS Registry. This large, diverse group helped ensure the tool accurately captures the challenges faced across the PWS community.

 

What Does the PWS Profile Measure?

The PWS Profile assesses eight key areas:

  • Rigidity and insistence on sameness
  • Aggressive behaviors
  • Repetitive questioning and speech
  • Compulsive behaviors
  • Depression and anxiety
  • Hoarding tendencies
  • Negative distorted thinking
  • Magical distorted thinking

There is also a smaller category focused on skin picking, a common behavior in PWS.

The PWS Profile has proven to be a reliable and valid tool, meaning it consistently measures what it’s supposed to and reflects the true experience of individuals with PWS. It works independently of IQ, weight, or family income, making it broadly applicable.

 

What’s Next? Using the PWS Profile to Improve Care

With the PWS Profile now available, it can be easily used in future clinical trials to evaluate the impact of medications and behavioral interventions not only on hyperphagia but also on the emotional and behavioral problems that are common in PWS. Additionally, the profile can also be used to track the natural history of a wide range of PWS symptoms over time. 

This important advancement wouldn’t be possible without the families who participate in studies like the PWS Global Registry and the PATH for PWS study. Your contributions provide the data that drive progress and give hope for better treatments ahead.

Together, we’re building a clearer picture of PWS—and with tools like the PWS Profile, we’re closer than ever to treatments that truly make a difference in the lives of our loved ones.

PWS global registry

  1. Dykens EM, Roof E, Hunt-Hawkins H. The Prader-Willi syndrome Profile: validation of a new measure of behavioral and emotional problems in Prader-Willi syndrome. Orphanet J Rare Dis. 2024 Feb 23;19(1):83. doi: 10.1186/s13023-024-03045-9. PMID: 38395848; PMCID: PMC10885615

  2. Miller JL, Gevers E, Bridges N, Yanovski JA, Salehi P, et al.  DESTINY PWS Investigators. Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial. J Clin Endocrinol Metab. 2023 Jun 16;108(7):1676-1685. doi: 10.1210/clinem/dgad014. PMID: 36639249; PMCID: PMC10271219.

  3. Miller JL, Gevers E, Bridges N, et al. Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study. Obesity (Silver Spring). 2024; 32(2): 252-261. doi:10.1002/oby.23928

Topics: News, Resource Development, Research, PWS People

Lauren Roth

author-image

Lauren Schwartz Roth, Ph.D., received a B.A. from University of California, San Diego and a Ph.D. in Clinical Psychology from the University of California, San Diego/San Diego State Joint Doctoral Program. She did her clinical internship and research postdoctoral studies at the University of Washington, Department of Psychiatry and Behavioral Sciences and Department of Rehabilitation Medicine studying the the impact of chronic illness and disability on patient well being with an emphasis on the physical and emotional impact on of living with and caring for someone with chronic illness/disability on families. She is a Clinical Associate Professor at the University of Washington, Department of Rehabilitation Medicine and also works as a research consultant for several outside organizations. Lauren is one of the early members of FPWR and served as Vice President and then President of the FPWR’s Board of Directors from 2004 to 2010. She remained on the Board of Directors until 2016. Lauren has also served on the FPWR's Scientific Advisory Board since 2009. She and her husband Mark have two beautiful daughters, including a 19 year old daughter with PWS.